Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × GSK2141795 × Clear all

NCT01958112 2019-05-31

GSK1120212+GSK2141795 for Cervical Cancer

Phase 2 Terminated

14 enrolled 10 charts

Uterine Cervical Neoplasms